In the last trading session, 12.7 million Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $17.59 changed hands at -$0.48 or -2.66% during last session, the market valuation stood at $20.16B. TEVA’s last price was a discount, traded about -29.62% off its 52-week high of $22.80. The share price had its 52-week low at $12.47, which suggests the last value was 29.11% up since then.
Analysts gave the Teva- Pharmaceutical Industries Ltd. ADR (TEVA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 1 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TEVA as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) trade information
Instantly TEVA was in red as seen at the end of in last trading. With action 2.33%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -20.19%, with the 5-day performance at 2.33% in the green. However, in the 30-day time frame, Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) is 3.90% up.
The consensus price target for the stock as assigned by Wall Street analysts is 28, meaning bulls need an upside of 37.18% from its current market value. According to analyst projections, TEVA’s forecast low is 28 with 28 as the target high. To hit the forecast high, the stock’s price needs a -59.18% plunge from its current level, while the stock would need to soar -59.18% for it to hit the projected low.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.62%. The 2025 estimates are for Teva- Pharmaceutical Industries Ltd. ADR earnings to increase by 1.95%, but the outlook for the next 5-year period is at 7.35% per year.
Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA)’s Major holders
FMR LLC holds the second largest percentage of outstanding shares, with 3.7051% or 41.98 million shares worth $682.15 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Contrafund and iShares Trust-iShares Core MSCI EAFE ETF. With 18.74 shares estimated at $329.56 million under it, the former controlled 1.63% of total outstanding shares. On the other hand, iShares Trust-iShares Core MSCI EAFE ETF held about 0.63% of the shares, roughly 7.19 shares worth around $126.54 million.
